Navigation Links
The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks
Date:5/21/2013

Toronto, Canada (PRWEB) May 21, 2013

As the R&D sector becomes increasingly competitive, there is a strong push within the industry to deliver better products, faster. Collaborations between Contract Development and Manufacturing Organizations and pharma companies often means turning big ideas into reality, within short time frames.

Microtablets, developed in collaboration with Sensidose AB and Recipharm, is one example of how effective outsourcing can bring products to market sooner. The partnership resulted in the development of a new dose automate delivery technology —slated to launch later this year— which can be customized to dispense medication according to individual requirement related to both dose amount and time.

In this webinar, keynote presenter Dr. Torkel Gren, Director at Recipharmm, will review how an effective collaboration between client and service provider can be achieved in outsourcing pharmaceutical development. The development of the microtablet, as well as how this concept can be used to develop new products of established active ingredients with a significantly improved therapeutic value, will be discussed.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtalks.com/Innovative-Microtablet-Dosage-Form-Development.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10737472.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development
2. Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes
3. Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
4. Winding River Productions Announces High-End Studio Enhancements Including SCORM-Compliant e-Learning Media Development and On-Location Data and Media Capture Platforms
5. Bayer CropScience Opens New Development North America Facilities in Research Triangle Park
6. Avenida Suites Hires Director for Global Business Development
7. A Media Event on Clinical Developments in Gene and Cell Therapy
8. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
9. TessArae, LLC and Chinese esoteric laboratory, Kindstar Global, secure partnership for development of genetic tests.
10. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
11. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):